Other. Pursuant to the terms of the Indenture, dated March 17, 2026, by and between Supernus, Inc. and U.S. Bank Trust Company, National Association…
Supernus, Inc. (INDV) filed an SEC Form 8-K — Other Events. Item 8.01 Other. Pursuant to the terms of the Indenture, dated March 17, 2026, by and between Supernus, Inc. (f/k/a Indivior Pharmaceuticals, Inc.; the “Company” or the “Registrant”) and U.S. Bank Trust Company, National Association (the “ Indenture ”), governing the Company's 0.
How this was made
The 30-second read
Why it matters
The conversion rate increased from 24.0033 to 30.9355 shares per $1,000 principal, implying an adjusted conversion price of about $32.33 per share. This updates the equity conversion payoff for noteholders and the hedging/dilution profile for common stock.
Market read
This is a capital-structure mechanics update for INDV’s convertible notes, relevant mainly to convertible arbitrage, hedging, and dilution modeling rather than to fundamentals.
What to watch
Traders may need to watch how the dividend was structured and whether any additional customary Indenture adjustments are expected, since conversion-rate changes can propagate into dealer hedging flows.
Background
The company’s 8-K Item 8.01 reports an Indenture-based conversion-rate increase for its 0.625% Convertible Senior Notes due 2031 following a board-declared special dividend on Sept. 16, 2026.
Ticker impact
Supernus disclosed an Indenture adjustment after a Sept. 16, 2026 special dividend, increasing the 2031 note conversion rate to 30.9355 shares.
Likely limited near-term move, with modest sensitivity from convertible arbitrage and dilution/hedge models to the revised conversion rate.
This is a mechanical conversion-rate adjustment tied to a special dividend, with no bond conversions reported and no new operating guidance or financing terms.
Market effects
Convertible note terms adjustments can marginally influence biotech capital-structure sentiment, but this is company-specific and not a sector-wide catalyst.
No direct regional macro linkage; impact is confined to INDV equity and its convertible complex.
Minimal, as the event is an issuer-specific SEC filing with no cross-border deal or regulatory action.
Counterpoint
Because no bondholders converted and the change is explicitly tied to a special dividend, the net economic effect on equity may be largely offset, limiting tradable impact.
Key entities
- issuerSupernus, Inc.
Filed an 8-K Item 8.01 describing an Indenture conversion-rate adjustment after a special dividend.
- trusteeU.S. Bank Trust Company, National Association
Indenture counterparty governing the company’s convertible notes.
- security0.625% Convertible Senior Notes due 2031
Convertible instrument whose conversion rate was increased per Indenture terms.
